Skip to main content
. 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355

Figure 1.

Figure 1

GS-331007 intracellular levels at 30 days of therapy correlated with sofosbuvir plasma concentrations at 30 days (A), at 60 days (B), at 90 days (C) and with daclatasvir (DAC) plasma concentrations at 7 days (D). p = p-value, P = Pearson coefficient.